1. Home
  2. Labeler Index
  3. Sandoz Inc.
  4. 0781-3476
  5. NDC Package Code: 0781-3476-95 Fondaparinux Sodium

NDC Package 0781-3476-95 Fondaparinux Sodium

Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0781-3476-95
Package Description:
10 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE (0781-3476-94)
Product Code:
0781-3476
Proprietary Name:
Fondaparinux Sodium
Non-Proprietary Name:
Fondaparinux Sodium
Substance Name:
Fondaparinux Sodium
Usage Information:
Fondaparinux is used to treat serious blood clots in the legs and/or lungs. It is usually used with another "blood thinner" medication (warfarin). If untreated, blood clots can travel to the lungs, heart, or brain, causing serious (possibly fatal) breathing problems, heart attack, or stroke. This drug may also be used to prevent blood clots after certain surgeries with an increased risk of blood clots (such as hip fracture, abdominal, knee/hip replacement). Fondaparinux is known as a "blood thinner" (anticoagulant). It is a drug similar to heparin that works by blocking certain natural substances in the blood that cause clotting.
11-Digit NDC Billing Format:
00781347695
NDC to RxNorm Crosswalk:
  • RxCUI: 861356 - fondaparinux sodium 10 MG in 0.8 ML Prefilled Syringe
  • RxCUI: 861356 - 0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe
  • RxCUI: 861356 - fondaparinux sodium 10 MG per 0.8 ML Prefilled Syringe
  • RxCUI: 861360 - fondaparinux sodium 2.5 MG in 0.5 ML Prefilled Syringe
  • RxCUI: 861360 - 0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sandoz Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • FONDAPARINUX SODIUM 10 mg/.8mL
    • Pharmacologic Class(es):
  • Factor Xa Inhibitor - [EPC] (Established Pharmacologic Class)
  • Factor Xa Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA206812
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    06-18-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0781-3476-95 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00781347695J1652Fondaparinux sodium0.5 MG0.81020200

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0781-3476-122 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE (0781-3476-94)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0781-3476-95?

    The NDC Packaged Code 0781-3476-95 is assigned to a package of 10 syringe in 1 carton / .8 ml in 1 syringe (0781-3476-94) of Fondaparinux Sodium, a human prescription drug labeled by Sandoz Inc.. The product's dosage form is injection and is administered via subcutaneous form.

    Is NDC 0781-3476 included in the NDC Directory?

    Yes, Fondaparinux Sodium with product code 0781-3476 is active and included in the NDC Directory. The product was first marketed by Sandoz Inc. on June 18, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0781-3476-95?

    The 11-digit format is 00781347695. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20781-3476-955-4-200781-3476-95